Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Identifieur interne : 002194 ( Main/Exploration ); précédent : 002193; suivant : 002195Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Auteurs : Claire Roger [France] ; Steven C. Wallis [Australie] ; Benjamin Louart [France] ; Jean-Yves Lefrant [France] ; Jeffrey Lipman [Australie] ; Laurent Muller [France] ; Jason A. Roberts [Australie]Source :
- The Journal of antimicrobial chemotherapy [ 1460-2091 ] ; 2016.
Descripteurs français
- KwdFr :
- Acinetobacter baumannii (), Acinetobacter baumannii (pathogénicité), Adulte d'âge moyen, Antibactériens (pharmacocinétique), Antibactériens (usage thérapeutique), Ciprofloxacine (pharmacocinétique), Ciprofloxacine (sang), Ciprofloxacine (usage thérapeutique), Escherichia coli (), Escherichia coli (pathogénicité), Femelle, Humains, Hémodiafiltration, Hémofiltration, Infections à Acinetobacter (microbiologie), Infections à Acinetobacter (traitement médicamenteux), Infections à Escherichia coli (microbiologie), Infections à Escherichia coli (traitement médicamenteux), Infections à Klebsiella (microbiologie), Infections à Klebsiella (traitement médicamenteux), Infections à Pseudomonas (microbiologie), Infections à Pseudomonas (traitement médicamenteux), Klebsiella pneumoniae (), Klebsiella pneumoniae (pathogénicité), Maladie grave, Mâle, Méthode de Monte-Carlo, Perfusions veineuses, Pseudomonas aeruginosa (), Pseudomonas aeruginosa (pathogénicité), Sepsie (traitement médicamenteux), Sujet âgé, Traitement substitutif de l'insuffisance rénale (), Unités de soins intensifs (), Études prospectives.
- MESH :
- microbiologie : Infections à Acinetobacter, Infections à Escherichia coli, Infections à Klebsiella, Infections à Pseudomonas.
- pathogénicité : Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa.
- pharmacocinétique : Antibactériens, Ciprofloxacine.
- sang : Ciprofloxacine.
- traitement médicamenteux : Infections à Acinetobacter, Infections à Escherichia coli, Infections à Klebsiella, Infections à Pseudomonas, Sepsie.
- usage thérapeutique : Antibactériens, Ciprofloxacine.
- Acinetobacter baumannii, Adulte d'âge moyen, Escherichia coli, Femelle, Humains, Hémodiafiltration, Hémofiltration, Klebsiella pneumoniae, Maladie grave, Mâle, Méthode de Monte-Carlo, Perfusions veineuses, Pseudomonas aeruginosa, Sujet âgé, Traitement substitutif de l'insuffisance rénale, Unités de soins intensifs, Études prospectives.
English descriptors
- KwdEn :
- Acinetobacter Infections (drug therapy), Acinetobacter Infections (microbiology), Acinetobacter baumannii (drug effects), Acinetobacter baumannii (pathogenicity), Aged, Anti-Bacterial Agents (pharmacokinetics), Anti-Bacterial Agents (therapeutic use), Ciprofloxacin (blood), Ciprofloxacin (pharmacokinetics), Ciprofloxacin (therapeutic use), Critical Illness, Escherichia coli (drug effects), Escherichia coli (pathogenicity), Escherichia coli Infections (drug therapy), Escherichia coli Infections (microbiology), Female, Hemodiafiltration, Hemofiltration, Humans, Infusions, Intravenous, Intensive Care Units (statistics & numerical data), Klebsiella Infections (drug therapy), Klebsiella Infections (microbiology), Klebsiella pneumoniae (drug effects), Klebsiella pneumoniae (pathogenicity), Male, Middle Aged, Monte Carlo Method, Prospective Studies, Pseudomonas Infections (drug therapy), Pseudomonas Infections (microbiology), Pseudomonas aeruginosa (drug effects), Pseudomonas aeruginosa (pathogenicity), Renal Replacement Therapy (methods), Sepsis (drug therapy).
- MESH :
- chemical , blood : Ciprofloxacin.
- chemical , pharmacokinetics : Anti-Bacterial Agents, Ciprofloxacin.
- drug effects : Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa.
- drug therapy : Acinetobacter Infections, Escherichia coli Infections, Klebsiella Infections, Pseudomonas Infections, Sepsis.
- methods : Renal Replacement Therapy.
- microbiology : Acinetobacter Infections, Escherichia coli Infections, Klebsiella Infections, Pseudomonas Infections.
- pathogenicity : Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa.
- statistics & numerical data : Intensive Care Units.
- chemical , therapeutic use : Anti-Bacterial Agents, Ciprofloxacin.
- Aged, Critical Illness, Female, Hemodiafiltration, Hemofiltration, Humans, Infusions, Intravenous, Male, Middle Aged, Monte Carlo Method, Prospective Studies.
Abstract
Whilst commonly performed in ICUs, renal replacement therapies (RRTs) differ in their solute clearances. There is a paucity of data on ciprofloxacin clearances in different RRT techniques. The aim of this study was to compare the population pharmacokinetics of ciprofloxacin during equal doses of continuous venovenous haemofiltration (CVVHF) and continuous venovenous haemodiafiltration (CVVHDF) in septic patients.
DOI: 10.1093/jac/dkw043
PubMed: 26957490
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001D41
- to stream PubMed, to step Curation: 001D17
- to stream PubMed, to step Checkpoint: 001D17
- to stream Ncbi, to step Merge: 003252
- to stream Ncbi, to step Curation: 003252
- to stream Ncbi, to step Checkpoint: 003252
- to stream Main, to step Merge: 002193
- to stream Main, to step Curation: 002194
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.</title><author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name><affiliation wicri:level="1"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia claire.roger@chu-nimes.fr.</nlm:affiliation><country wicri:rule="url">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Wallis, Steven C" sort="Wallis, Steven C" uniqKey="Wallis S" first="Steven C" last="Wallis">Steven C. Wallis</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Louart, Benjamin" sort="Louart, Benjamin" uniqKey="Louart B" first="Benjamin" last="Louart">Benjamin Louart</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Lefrant, Jean Yves" sort="Lefrant, Jean Yves" uniqKey="Lefrant J" first="Jean-Yves" last="Lefrant">Jean-Yves Lefrant</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Muller, Laurent" sort="Muller, Laurent" uniqKey="Muller L" first="Laurent" last="Muller">Laurent Muller</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia Pharmacy Department, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia Pharmacy Department, Royal Brisbane and Womens' Hospital, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26957490</idno><idno type="pmid">26957490</idno><idno type="doi">10.1093/jac/dkw043</idno><idno type="wicri:Area/PubMed/Corpus">001D41</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D41</idno><idno type="wicri:Area/PubMed/Curation">001D17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D17</idno><idno type="wicri:Area/PubMed/Checkpoint">001D17</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D17</idno><idno type="wicri:Area/Ncbi/Merge">003252</idno><idno type="wicri:Area/Ncbi/Curation">003252</idno><idno type="wicri:Area/Ncbi/Checkpoint">003252</idno><idno type="wicri:Area/Main/Merge">002193</idno><idno type="wicri:Area/Main/Curation">002194</idno><idno type="wicri:Area/Main/Exploration">002194</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.</title><author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name><affiliation wicri:level="1"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia claire.roger@chu-nimes.fr.</nlm:affiliation><country wicri:rule="url">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Wallis, Steven C" sort="Wallis, Steven C" uniqKey="Wallis S" first="Steven C" last="Wallis">Steven C. Wallis</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Louart, Benjamin" sort="Louart, Benjamin" uniqKey="Louart B" first="Benjamin" last="Louart">Benjamin Louart</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Lefrant, Jean Yves" sort="Lefrant, Jean Yves" uniqKey="Lefrant J" first="Jean-Yves" last="Lefrant">Jean-Yves Lefrant</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Muller, Laurent" sort="Muller, Laurent" uniqKey="Muller L" first="Laurent" last="Muller">Laurent Muller</name><affiliation wicri:level="3"><nlm:affiliation>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des réanimations, Pôle Anesthésie Réanimation Douleur Urgence, CHU Nîmes, Nîmes, France Equipe d'Accueil 2992, Faculté de Médecine de Nîmes, Université de Montpellier, Nimes</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Nîmes</settlement></placeName></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia Pharmacy Department, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Department of Intensive Care Medicine, Royal Brisbane and Womens' Hospital, Brisbane, Queensland, Australia Pharmacy Department, Royal Brisbane and Womens' Hospital, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of antimicrobial chemotherapy</title><idno type="eISSN">1460-2091</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acinetobacter Infections (drug therapy)</term><term>Acinetobacter Infections (microbiology)</term><term>Acinetobacter baumannii (drug effects)</term><term>Acinetobacter baumannii (pathogenicity)</term><term>Aged</term><term>Anti-Bacterial Agents (pharmacokinetics)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Ciprofloxacin (blood)</term><term>Ciprofloxacin (pharmacokinetics)</term><term>Ciprofloxacin (therapeutic use)</term><term>Critical Illness</term><term>Escherichia coli (drug effects)</term><term>Escherichia coli (pathogenicity)</term><term>Escherichia coli Infections (drug therapy)</term><term>Escherichia coli Infections (microbiology)</term><term>Female</term><term>Hemodiafiltration</term><term>Hemofiltration</term><term>Humans</term><term>Infusions, Intravenous</term><term>Intensive Care Units (statistics & numerical data)</term><term>Klebsiella Infections (drug therapy)</term><term>Klebsiella Infections (microbiology)</term><term>Klebsiella pneumoniae (drug effects)</term><term>Klebsiella pneumoniae (pathogenicity)</term><term>Male</term><term>Middle Aged</term><term>Monte Carlo Method</term><term>Prospective Studies</term><term>Pseudomonas Infections (drug therapy)</term><term>Pseudomonas Infections (microbiology)</term><term>Pseudomonas aeruginosa (drug effects)</term><term>Pseudomonas aeruginosa (pathogenicity)</term><term>Renal Replacement Therapy (methods)</term><term>Sepsis (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acinetobacter baumannii ()</term><term>Acinetobacter baumannii (pathogénicité)</term><term>Adulte d'âge moyen</term><term>Antibactériens (pharmacocinétique)</term><term>Antibactériens (usage thérapeutique)</term><term>Ciprofloxacine (pharmacocinétique)</term><term>Ciprofloxacine (sang)</term><term>Ciprofloxacine (usage thérapeutique)</term><term>Escherichia coli ()</term><term>Escherichia coli (pathogénicité)</term><term>Femelle</term><term>Humains</term><term>Hémodiafiltration</term><term>Hémofiltration</term><term>Infections à Acinetobacter (microbiologie)</term><term>Infections à Acinetobacter (traitement médicamenteux)</term><term>Infections à Escherichia coli (microbiologie)</term><term>Infections à Escherichia coli (traitement médicamenteux)</term><term>Infections à Klebsiella (microbiologie)</term><term>Infections à Klebsiella (traitement médicamenteux)</term><term>Infections à Pseudomonas (microbiologie)</term><term>Infections à Pseudomonas (traitement médicamenteux)</term><term>Klebsiella pneumoniae ()</term><term>Klebsiella pneumoniae (pathogénicité)</term><term>Maladie grave</term><term>Mâle</term><term>Méthode de Monte-Carlo</term><term>Perfusions veineuses</term><term>Pseudomonas aeruginosa ()</term><term>Pseudomonas aeruginosa (pathogénicité)</term><term>Sepsie (traitement médicamenteux)</term><term>Sujet âgé</term><term>Traitement substitutif de l'insuffisance rénale ()</term><term>Unités de soins intensifs ()</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Ciprofloxacin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Ciprofloxacin</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Acinetobacter baumannii</term><term>Escherichia coli</term><term>Klebsiella pneumoniae</term><term>Pseudomonas aeruginosa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acinetobacter Infections</term><term>Escherichia coli Infections</term><term>Klebsiella Infections</term><term>Pseudomonas Infections</term><term>Sepsis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Renal Replacement Therapy</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections à Acinetobacter</term><term>Infections à Escherichia coli</term><term>Infections à Klebsiella</term><term>Infections à Pseudomonas</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Acinetobacter Infections</term><term>Escherichia coli Infections</term><term>Klebsiella Infections</term><term>Pseudomonas Infections</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Acinetobacter baumannii</term><term>Escherichia coli</term><term>Klebsiella pneumoniae</term><term>Pseudomonas aeruginosa</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Acinetobacter baumannii</term><term>Escherichia coli</term><term>Klebsiella pneumoniae</term><term>Pseudomonas aeruginosa</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Antibactériens</term><term>Ciprofloxacine</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Ciprofloxacine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Intensive Care Units</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Ciprofloxacin</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à Acinetobacter</term><term>Infections à Escherichia coli</term><term>Infections à Klebsiella</term><term>Infections à Pseudomonas</term><term>Sepsie</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Ciprofloxacine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Critical Illness</term><term>Female</term><term>Hemodiafiltration</term><term>Hemofiltration</term><term>Humans</term><term>Infusions, Intravenous</term><term>Male</term><term>Middle Aged</term><term>Monte Carlo Method</term><term>Prospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acinetobacter baumannii</term><term>Adulte d'âge moyen</term><term>Escherichia coli</term><term>Femelle</term><term>Humains</term><term>Hémodiafiltration</term><term>Hémofiltration</term><term>Klebsiella pneumoniae</term><term>Maladie grave</term><term>Mâle</term><term>Méthode de Monte-Carlo</term><term>Perfusions veineuses</term><term>Pseudomonas aeruginosa</term><term>Sujet âgé</term><term>Traitement substitutif de l'insuffisance rénale</term><term>Unités de soins intensifs</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Whilst commonly performed in ICUs, renal replacement therapies (RRTs) differ in their solute clearances. There is a paucity of data on ciprofloxacin clearances in different RRT techniques. The aim of this study was to compare the population pharmacokinetics of ciprofloxacin during equal doses of continuous venovenous haemofiltration (CVVHF) and continuous venovenous haemodiafiltration (CVVHDF) in septic patients.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li></country><region><li>Languedoc-Roussillon</li><li>Occitanie (région administrative)</li></region><settlement><li>Nîmes</li></settlement></list><tree><country name="France"><noRegion><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name></noRegion><name sortKey="Lefrant, Jean Yves" sort="Lefrant, Jean Yves" uniqKey="Lefrant J" first="Jean-Yves" last="Lefrant">Jean-Yves Lefrant</name><name sortKey="Louart, Benjamin" sort="Louart, Benjamin" uniqKey="Louart B" first="Benjamin" last="Louart">Benjamin Louart</name><name sortKey="Muller, Laurent" sort="Muller, Laurent" uniqKey="Muller L" first="Laurent" last="Muller">Laurent Muller</name></country><country name="Australie"><noRegion><name sortKey="Wallis, Steven C" sort="Wallis, Steven C" uniqKey="Wallis S" first="Steven C" last="Wallis">Steven C. Wallis</name></noRegion><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002194 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002194 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26957490
|texte= Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26957490" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |